Evidence map›Paper›PMID 40528407›Full record

ReviewAnnals of laboratory medicine2025

Advancing Accuracy in Chronic Kidney Disease Diagnosis and Management: Reference Materials and Reference Measurement Procedures for Clinical Markers.

Hwee Tong Tan, Qinde Liu, Tang Lin Teo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Measuring urine albumin and total protein.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hwee Tong TanChemical Metrology Division, Applied Sciences Group, Health Sciences Authority, Singapore, Singapore.ORCID https://orcid.org/0000-0002-2681-0701
Qinde LiuChemical Metrology Division, Applied Sciences Group, Health Sciences Authority, Singapore, Singapore.ORCID https://orcid.org/0000-0003-0769-4642
Tang Lin TeoChemical Metrology Division, Applied Sciences Group, Health Sciences Authority, Singapore, Singapore.ORCID https://orcid.org/0000-0002-1991-4158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a major non-communicable disease and a leading cause of mortality worldwide. With the increasing prevalence of risk factors such as diabetes mellitus, obesity, and hypertension in the 21st century, CKD currently affects over 10% of the global population. The clinical and economic burden of this widespread disease is projected to continue to rise worldwide. Early detection, treatment, and monitoring of this progressive condition through accurate clinical laboratory testing of CKD biomarkers are paramount to mitigate this growing healthcare challenge. The development of reference materials (RMs) and reference measurement procedures (RMPs) for these clinical analytes is pivotal to ensuring accurate measurements using

Indexed as

BiomarkersRenal Insufficiency, ChronicAlbuminuriaCreatinineCystatin CHumansReference StandardsUreaBiomarkersCreatinineCystatin CUreaAlbuminChronic kidney diseaseCreatinineCystatin CReference materialReference measurement procedureUrea

Identifiers

PMID40528407
PMCPMC12187498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.